Proton Pump Inhibitors and Clopidogrel

Karpman, Harold L.
June 2011
Internal Medicine Alert;6/29/2011, Vol. 33 Issue 12, p92
Proton pump inhibitor use in clopidogreltreated post-percutaneous coronary intervention patients was not associated with an increased risk of all-cause death, nonfatal myocardial infarction, repeat revascularization, or major adverse cardiovascular events.


Related Articles

  • Clopidogrel plus proton pump inhibitor linked with increased risk for rehospitalization.  // Cardiology Today;Jun2010, Vol. 13 Issue 6, p32 

    The article presents a study about the link between combined clopidogrel and proton pump inhibitor and rehospitalization after a myocardial infarction (MI) or stent placement, published in an issue of "Archives of Internal Medicine."

  • Prescribing proton pump inhibitors with clopidogrel. Targownik, Laura Ellyn // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;8/11/2012, Vol. 345 Issue 7869, p6 

    The author comments on a study by Douglas and colleagues who analysed whether proton pump inhibitors (PPIs) cause myocardial infarction in users of aspirin and clopidogrel. The study concluded that once residual confounding is minimised no association exists between myocardial infarction and PPI...

  • Clopidogrel plus proton pump inhibitor linked with increased risk for rehospitalization.  // Hem/Onc Today;5/25/2010, Vol. 11 Issue 10, p8 

    The article discusses the study about the impact of taking clopidrogel combined with proton pump inhibitor on risk for rehospitalization following a myocardial infarction or stent placement by researchers from Irvine, California and Seattle.

  • Effects of the short-term application of pantoprazole combined with aspirin and clopidogrel in the treatment of acute STEMI. PENG WEI; YI-GANG ZHANG; LIN LING; ZI-QI TAO; LI-YA JI; JIE BAI; BIN ZONG; CHUN-YING JIANG; QIAN ZHANG; QIANG FU; XIANG-JUN YANG // Experimental & Therapeutic Medicine;Nov2016, Vol. 12 Issue 5, p2861 

    The aim of the present study was to determine the effects of the short-term application of pantoprazole on the co-treatment of acute ST-segment elevation myocardial infarction (STEMI) with aspirin and clopidogrel. A total of 207 acute patients showing primary symptoms of STEMI, who received...

  • Review Article: Combination of Clopidogrel and Proton Pump Inhibitors: Implications for Clinicians. Tran, Marie; Tafreshi, Javad; Pai, Ramdas G. // Journal of Cardiovascular Pharmacology & Therapeutics;Dec2010, Vol. 15 Issue 4, p326 

    Objectives: To evaluate the existing literature on a proposed interaction between clopidogrel and proton pump inhibitors (PPIs) and discuss its implications for clinicians treating patients with this combination therapy. Background: Each year millions of patients receive antiplatelet therapy. A...

  • Warning over PPI use after an MI. Anekwe, Lilian // Pulse;9/22/2010, Vol. 70 Issue 27, p8 

    The article focuses on the result of the study which shows that proton pump inhibitors prescription to patients with myocardial infarction increases the risk of cardiovascular events.

  • Safety of proton pump inhibitors. Elliott, William T. // Clinical Oncology Alert;Nov2010 Supplement, p1 

    This article focuses on a Danish study which examined the safety of proton pump inhibitors (PPIs) in patients who were hospitalized for myocardial infarction (MI). Results of the study showed that there were similar rates of death or rehospitalization among patients who were discharged on a...

  • Influence of different proton pump inhibitors on platelet function in acute myocardial infarction patients receiving clopidogrel treatment after percutaneous coronary intervention. Zhe Wang; Xinchun Yang; Jun Cai; Mulei Chen; Xinhong Wan // Biomedical Research (0970-938X);2013, Vol. 24 Issue 4, p453 

    The objective of the present study is to investigate the effect of clopidogrel and proton pump inhibitors (PPIs) on upper gastrointestinal bleeding and adverse cardiovascular events in acute myocardial infarction (MI) patients after percutaneous coronary intervention (PCI). A total of 240...

  • Evidence-Based Medicine.  // Clinical Advisor;Dec2009, Vol. 12 Issue 12, p76 

    The article offers several practice guidelines that are evidence-based. B-type natriuretic peptide (BNP) and its N-terminal fragment (NT-proBNP) can offer useful diagnostic and prognostic information in patients with acute dyspnea and chronic heart failure. Prophylactic acetaminophen or...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics